research programme - Robuta Search

https://www.wcrp-climate.org/ World Climate Research Programme (WCRP) The aims of WCRP is to facilitate analysis and prediction of Earth System variability and change for use in an increasing range of practical applications of... world climate research programme wcrp https://adisinsight.springer.com/drugs/800086902?error=cookies_not_supported&code=9a31a4d8-73fd-43f6-8472-d0142442eafb Research programme: chronic heart failure therapeutic - Spur Therapeutics - AdisInsight Gene therapy is being developed by Spur Therapeutics for the treatment of chronic heart failure. Early research is ongoing in the United Kingdom. chronic heart failure research programme spur therapeutics adisinsight https://actu.epfl.ch/news/a-new-national-research-programme-recognizes-epfl/ A new national research programme recognizes EPFL's expertise - EPFL a new national research programme recognizes epfl https://adisinsight.springer.com/drugs/800046654?error=cookies_not_supported&code=4d10783b-5694-4803-9381-b153fca80502 Research programme: protozoan infection therapeutics - Synstar Japan - AdisInsight Synstar Japan is developing compounds for the treatment of African trypanosomiasis, Chagas disease and Leishmaniasis. Development is at the lead optimisation research programme protozoan infection therapeutics japan https://adisinsight.springer.com/drugs/800031292?error=cookies_not_supported&code=648e7698-612e-46f1-9b43-2ddb2f89aba4 Research programme: vaccines - Sinovac (Dalian) Vaccine Technology - AdisInsight Sinovac (Dalian) Vaccine Technology is a joint venture company established by Sinovac Biotech and Dalian Jin Gang Group, to research, develop, manufacture and research programme vaccine technology vaccines sinovac dalian https://adisinsight.springer.com/drugs/800053708?error=cookies_not_supported&code=9c01f435-e490-4333-939b-600dd15e815f Research programme: T cell therapeutics - Adaptive Biotechnologies/Genentech - AdisInsight Neoantigen directed personalised T-cell therapies are being developed by Adaptive Biotechnologies in collaboration with Genentech for the treatment of a broad research programme t cell adaptive biotechnologies therapeutics genentech https://medicinehealth.leeds.ac.uk/medicine/dir-record/research-groups/902/myeloma-uk-concept-and-access-research-programme Myeloma UK Concept and Access Research Programme | Research groups | School of Medicine |... In partnership with Myeloma UK, our research at the Leeds Myeloma UK CARP aims to delivery more trials, more quickly to patients with multiple myeloma and to... myeloma uk access research school of concept https://www.lse.ac.uk/business/consulting/reports/student-opportunity-outcomes-framework Student Opportunity Outcomes Framework Research Programme: Data Return Project Download the report "Student Opportunity Outcomes Framework Research Programme: Data Return Project", written by Lindsey Bowes, et al. student opportunity outcomes framework research programme data return https://docs.google.com/forms/d/1Q4F_tIRkovCtcdiU8xpnGEI2lFlCeUQAReaKfx85T0g/closedform Summer Undergraduate Research Programme (SURP)-2026 Summer Undergraduate Research Programme of 6 weeks duration is scheduled from 1st June to 10th July 2026. The Programme consists of 2 hours of lecture per week... summer undergraduate research programme surp https://adisinsight.springer.com/drugs/800084087?error=cookies_not_supported&code=eaab1e3d-4bc4-4246-a9f6-c31887768c27 Research programme: bacteriophage therapies - iNtRON Biotechnology - AdisInsight iNtRON Biotechnology is developing bacteriophage therapies are being developed by iNtRON Biotechnology for the treatment of cancer, neurodegenerative disorders research programme intron biotechnology bacteriophage therapies adisinsight https://adisinsight.springer.com/drugs/800042047?error=cookies_not_supported&code=01cdebd5-e559-4a9e-9edb-1b71c135157e Research programme: Neurodegenerative disorders therapeutics - Alzheimer's Drug Discovery... Pfizer's Centers for Therapeutic Innovation (CTI), in collaboration with Alzheimer's Drug Discovery Foundation, is developing therapeutics for the treatment of research programme neurodegenerative disorders therapeutics alzheimer drug https://adisinsight.springer.com/drugs/800086502?error=cookies_not_supported&code=a5a7631a-76e4-4e14-92d8-06e1884fe317 Research programme: cancer therapeutics - OTR Therapeutics - AdisInsight Cancer therapeutics is being developed by OTR Therapeutics for the treatment of cancer. Early research is underway in China. research programme cancer therapeutics otr adisinsight https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRPHDANAYS1F&year=2026 Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://www.birmingham.ac.uk/research/centres-institutes/research-in-nursing-and-midwifery/risk-abuse-and-violence-research-programme Risk, Abuse and Violence Research Programme - University of Birmingham In the Risk, Abuse and Violence (RAV) research programme we undertake multi-disciplinary and international projects that address violence and abuse, and myriad... abuse and violence research programme university of risk birmingham https://cordis.europa.eu/programme/id/H2020_SC5-03-2016 Climate services market research | Programme | H2020 | CORDIS | European Commission climate services market research programme cordis european https://adisinsight.springer.com/drugs/800028414?error=cookies_not_supported&code=76fbcf26-dca8-480d-b02b-4dd869aa3cdd Research programme: acute myelogenous leukaemia therapy - Provid Pharmaceuticals/The Leukemia &... research programme acute leukaemia therapy pharmaceuticals https://adisinsight.springer.com/drugs/800083047?error=cookies_not_supported&code=13c39fb2-a601-49e0-98d3-858a254cbb17 Research programme: fibrotic disease therapeutics - Gero/Pfizer - AdisInsight Anti-fibrotic therapeutics being developed by Gero in collaboration of Pfizer. Candidates are being developed utilizing machine learning technology platform by research programme disease therapeutics gero pfizer https://openresearch-repository.anu.edu.au/items/27fd534d-c0ab-4a27-a361-19f26c96346b The methodology of the public choice research programme: the case of 'voting with feet' the methodology public choice research programme https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRPHDCECRC1F&year=2026 Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://adisinsight.springer.com/drugs/800044621?error=cookies_not_supported&code=232d3142-87df-410f-bd06-15ba317d657b Research programme: therapeutics - Shiner Pharm - AdisInsight Shiner Pharm is developing several therapetuic products for the treatment of diseases in various therapeutic areas. Product IM (oncology), Product EM research programme therapeutics shiner pharm adisinsight https://adisinsight.springer.com/drugs/800035435?error=cookies_not_supported&code=624b5f6d-4007-4eca-9124-8fadd9c15e66 Research programme: pain therapeutics and companion diagnostics - Genentech/Xenon Pharmaceuticals -... Genentech, in collaboration with Xenon Pharmaceuticals, was developing oral small molecule therapeutics and companion diagnostics, for the treatment of pain research programme companion diagnostics pain therapeutics genentech https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRPHDARCHS1P&year=2026 Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRPHDCECRC1F Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://cordis.europa.eu/programme/id/PRE_FWP_ENVIRO-2C Research programme (EEC) in the environmental field (indirect action), 1976-1980 | Programme |... research programme in the eec https://www.ecb.europa.eu/press/conferences/html/20191218_Legal_research_programme_2020.ga.html Legal Research Programme 2020 - Call for papers The European Central Bank (ECB) is the central bank of the European Union countries which have adopted the euro. Our main task is to maintain price stability... legal research call for programme papers https://www.helsinki.fi/en/researchgroups/migration-care-and-ageing/research-programme Research Programme | Migration, Care and Ageing | University of Helsinki Explore our research agenda. research programme university of migration care ageing https://adisinsight.springer.com/drugs/800043225?error=cookies_not_supported&code=5ea5e31f-34dd-4b0d-9ac8-ff30b0aa1452 Research programme: anti-cancer therapeutics - University of South Australia - AdisInsight The University of South Australia is developing therapeutics for the treatment of cancer. Early research is underway in Australia. Yabao Pharmaceutical Group is university of south australia research programme anti cancer therapeutics adisinsight https://adisinsight.springer.com/drugs/800017209?error=cookies_not_supported&code=a276f4f1-97a5-45b6-9feb-8e9cad9be82d Research programme: tubulin polymerisation inhibitors - Abbott - AdisInsight Abbott Laboratories (now AbbVie) was developing compounds that are capable of inhibiting tubulin polymerisation. The lead compounds from this research research programme tubulin polymerisation inhibitors abbott https://adisinsight.springer.com/drugs/800060695?error=cookies_not_supported&code=67c142cd-47c3-4fef-9cca-6a5acbc7f4b0 Research programme: small molecule therapeutics - ABM Therapeutics - AdisInsight Small molecule therapeutics targeting cancer are being developed by ABM Therapeutics. The research programme involves molecules inhibiting src, STAT3 and research programme small molecule therapeutics abm adisinsight https://cordis.europa.eu/article/id/14420-launch-of-aero-engine-research-programme Launch of aero engine research programme | News | CORDIS | European Commission The European Commission launched its largest ever aero engine research programme, costing over 100 million euro, on 1 March 2000. The... aero engine research programme launch news cordis https://economictimes.indiatimes.com/industry/services/education/india-foundation-for-the-arts-invites-applications-for-arts-research-programme/printarticle/64738525.cms India Foundation for the Arts invites applications for Arts Research Programme - The Economic Times IFA especially encourages proposals in Indian languages. Evaluation, conducted with the help of external domain experts, will consider the relative merit and... for the arts research programme india foundation https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRMSCFRFRS1P&year=2026 Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://research-office.ed.ac.uk/ecosystem-services-for-poverty-alleviation-espa-research-programme?s=year&o=asc Ecosystem Services for Poverty Alleviation ESPA research programme | Edinburgh Research Office |... ESPA (Ecosystem services for poverty alleviation) was a 9-year UK research programme to explore the links between the environment and human wellbeing. ecosystem services poverty alleviation research programme espa edinburgh https://adisinsight.springer.com/drugs/800086958?error=cookies_not_supported&code=f6e7b67d-61a9-4c5c-b210-58b860196dfd Research programme: CAR-NK cell therapies - Cartherics/Ticaros - AdisInsight Chimeric antigen receptor-natural killer (CAR-NK) cell therapeutics derived from induced pluripotent stem cells are being developed by Cartherics and Ticaros research programme nk cell car therapies adisinsight https://adisinsight.springer.com/drugs/800086783?error=cookies_not_supported&code=8d9103d5-c2c7-4ff3-b630-0dcd5fbf1446 Research programme: small molecule therapeutics - Alchemedicine/Asahi Kasei Pharma - AdisInsight Small molecule therapeutics are being developed by Asahi Kasei Pharma under the license from Alchemedicine for the treatment of autoimmune diseases. Preclinical research programme small molecule asahi kasei therapeutics pharma https://students.leeds.ac.uk/leadership-programmes/doc/laidlaw-leadership-research-programme Laidlaw Leadership and Research Programme | Students | University of Leeds Find out about the fully funded Laidlaw Leadership and Research Programme, how it works, the benefits of becoming a Laidlaw scholar, key dates and how to apply. research programme university of laidlaw leadership students https://adisinsight.springer.com/drugs/800043958?error=cookies_not_supported&code=8956d9ef-2b68-475f-a007-e76fb490fd17 Research programme: intranasal chlamydia vaccine - BlueWillow Biologics - AdisInsight An intranasal nanoemulsion-based adjuvanted mucosal vaccine is being developed by BlueWillow Biologics (formerly NanoBio Corporation) for the prevention of research programme intranasal chlamydia vaccine bluewillow https://www.cnrs.fr/en/pepr/high-temperature-supraconductors-fusion-suprafusion National research programme High-temperature superconductors and fusion (PEPR SupraFusion) | CNRS national research high temperature programme https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRPHDGEOGE1F&year=2026 Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://johnian.joh.cam.ac.uk/news/the-edward-showler-foundation-launches-clear-cell-sarcoma-research-programme/ The Edward Showler Foundation launches Clear Cell Sarcoma Research Programme - Johnian Jan 7, 2022 - Alumnus Dr Edward Showler ('Ed')(2007) died at the age of 28 from clear cell sarcoma. The Edward Showler Foundation has just launched a new programme of... clear cell research programme edward foundation launches https://adisinsight.springer.com/drugs/800044078?error=cookies_not_supported&code=c55e53a1-9f5c-4ac0-afe3-018e31f6ba8a Research programme: botanic anticancer therapeutics - JoBen Bio-Medical/Development Center for... JoBen Bio-Medical, in collaboration with the Development Center for Biotechnology, is developing new botanic, anticancer drugs based on chemical ingredients research programme bio medical development center botanic anticancer https://adisinsight.springer.com/drugs/800027103?error=cookies_not_supported&code=1335863e-fdd0-42ea-9e07-9d0b75482bad Research programme: RNAi therapeutics - SomaGenics - AdisInsight SomaGenics and its collaborators Roche and Arbutus Biopharma (formerly Tekmira Pharmaceuticals) are developing short hairpin RNA (sshRNA)-based therapeutics research programme rnai therapeutics adisinsight https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRMTHTHERS1P&year=2026 Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://adisinsight.springer.com/drugs/800024508?error=cookies_not_supported&code=5cbfbdda-591b-42c1-8268-489103ea6354 Research programme: poloxamer-188 therapeutics - Maroon Biotech - AdisInsight Maroon Biotech is researching the use of poloxamer-188 [P-188], a synthetic surfactant, for the potential treatment of spinal cord injuries, traumatic brain research programme poloxamer therapeutics maroon biotech https://www.research.ed.ac.uk/en/projects/organic-supramolecular-chemistry-a-research-programme-of-syntheti/fingerprints/ Organic supramolecular chemistry: A Research programme of synthetic molecular motors and machines -... supramolecular chemistry research programme https://adisinsight.springer.com/drugs/800060106?error=cookies_not_supported&code=5aa1d747-d52a-419e-a35f-2a4111e5aeae Research programme: monoclonal antibodies - TrueBinding - AdisInsight Monoclonal antibodies that blocks checkpoint inhibitor interactions are being developed by TrueBinding for the treatment of cancer. The candidates are being research programme monoclonal antibodies adisinsight https://adisinsight.springer.com/drugs/800087063?error=cookies_not_supported&code=75bc4a90-14b3-446c-994d-6b0579a97e81 Research programme: polymer nanovesicles directed gene therapeutics - Vianautis - AdisInsight Polymer nanovesicles directed gene therapeutics are being developed by Vianautis for the treatment of immunological disorders, inflammation and cancer. research programme polymer directed gene therapeutics https://adisinsight.springer.com/drugs/800031670?error=cookies_not_supported&code=2d3c9224-c066-404c-8e0a-11db86582036 Research programme: prodrug therapeutics - Sanofi - AdisInsight Prodrug therapeutics are being developed by Sanofi, under a license from Ascendis Pharma, using the latter's TransCon technology. This technology enables the research programme therapeutics sanofi adisinsight https://www.medarbetarwebben.lu.se/lucat/group/v1001498 Norma Research Programme | Medarbetarwebben research programme norma medarbetarwebben https://adisinsight.springer.com/drugs/800029405?error=cookies_not_supported&code=99fa5411-0e4b-40c9-94ff-3745fe7bd73f Research programme: diacylglycerol transferase-1 inhibitors - Madrigal Pharmaceuticals - AdisInsight Madrigal Pharmaceuticals (formerly VIA Pharmaceuticals) is developing diacylglycerol transferase-1 (DGAT1) inhibitors for the treatment of metabolic disorders, research programme madrigal pharmaceuticals diacylglycerol transferase inhibitors https://adisinsight.springer.com/drugs/800049587?error=cookies_not_supported&code=448ec6d8-d6c6-4404-8b3f-8b43b05302b1 Research programme: anticancer monoclonal antibodies - Nybo Therapeutics - AdisInsight Nybo Therapeutics, the immuno-oncology subsidiary of PureTech Health is developing monoclonal antibodies to target immuno-suppressive gamma delta T cells in research programme monoclonal antibodies anticancer nybo therapeutics https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRMSCCOUST1P&year=2026 Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://cordis.europa.eu/article/id/798-projects-selected-for-4th-agricultural-research-programme Projects selected for 4th agricultural research programme | News | CORDIS | European Commission 659 proposals were received by the Commission after the 1990 and 1991 calls for proposals concerning the programme of RTD in the field of... agricultural research programme news projects selected https://adisinsight.springer.com/drugs/800087329?error=cookies_not_supported&code=bea2c50d-c900-4040-be7e-2621a9c285f0 Research programme: small molecule therapeutics - 26therapeutics - AdisInsight Topical small-molecule therapeutics are being developed by 26therapeutics for the treatment of Dry Eye Disease and other meibomian gland disorders, utilizing a research programme small molecule therapeutics adisinsight https://cordis.europa.eu/article/id/428847-386-million-eur-research-programme-on-neurodegeneration-featured-at-alzheimer-europe-conferen/pl 386 Million EUR Research Programme on Neurodegeneration Featured at Alzheimer Europe Conference |... Neuronet Public Event Features Major European Research Projects on Alzheimer's Disease and Beyond During the Virtual Alzheimer Europe... research programme https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRMPHBIOLS1F&year=2026 Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://adisinsight.springer.com/drugs/800086580?error=cookies_not_supported&code=08f4f255-e769-48b5-926c-c0a3353b52da Research programme: neurodegenerative disorders - Change Cure - AdisInsight Neurodegenerative disorders therapeutics is being developed by Change Cure for the treatment of neurodegenerative disorders including spinocerebellar ataxia research programme neurodegenerative disorders change cure adisinsight https://adisinsight.springer.com/drugs/800086981?error=cookies_not_supported&code=17b93a03-b002-4994-93de-40e9b0683680 Research programme: antibody-drug conjugates - Klasther Biopharma - AdisInsight Antibody-drug conjugates directed against tumor-specific post-translational modifications (PTMs) are being developed by Klasther Biopharma (spin-off from the antibody drug conjugates research programme biopharma adisinsight https://cordis.europa.eu/programme/id/FP4-BIOMED-2_7.2 Human genome research | Programme | FP4 | CORDIS | European Commission human genome research programme cordis european commission https://adisinsight.springer.com/drugs/800027209?error=cookies_not_supported&code=6d1e0abe-124c-49ef-bea5-7837bc7b5e19 Research programme: cardiovascular disease therapies - Amarin - AdisInsight Amarin Corporation is developing unsaturated fatty acid derivatives for the treatment of cardiovascular disease. The company intends to develop new compounds research programme cardiovascular disease therapies amarin adisinsight https://adisinsight.springer.com/drugs/800030206?error=cookies_not_supported&code=330a4866-c2ef-4dd2-8518-7ccec98f4f3f Research programme: paracetamol prodrugs - NeurogesX - AdisInsight NeurogesX is developing prodrugs of paracetamol (acetaminophen) for the treatment of pain. Two lead compounds, NGX 9674 and NGX 5752, have demonstrated improved research programme paracetamol prodrugs adisinsight https://adisinsight.springer.com/drugs/800022022?error=cookies_not_supported&code=d7ec754c-2924-41a7-b101-64df23305ec8 Research programme: anti-HIV agents - Quigley Pharma - AdisInsight Quigley Pharma is developing a naturally derived antiviral compound, QR 437, for the prevention of HIV infection. In Quigley Pharma's 2008 annual report, the research programme anti hiv agents quigley pharma https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRPHDINFME1P&year=2026 Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://adisinsight.springer.com/drugs/800038135?error=cookies_not_supported&code=05092f42-2ec7-462b-a9b0-72efb57a0b04 Research programme: protein-protein interaction inhibitors - HQL Pharmaceuticals - AdisInsight HQL Pharmaceuticals is discovering and developing protein-protein interaction (PPI) inhibitors, that target the apoptosis-regulating pathway, for the treatment research programme protein interaction inhibitors hql pharmaceuticals https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRMSCINFLA1F&year=2026 Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://www.physics.ox.ac.uk/research/subdepartment/atomic-and-laser-physics/atomic-and-laser-summer-research-programme Atomic and Laser Summer Research Programme | University of Oxford Department of Physics Find out about summer research internships in Atomic and Laser Physics for undergraduate students. summer research programme university of oxford atomic laser https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRPHDDISNS1P&year=2026 Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://adisinsight.springer.com/drugs/800060844?error=cookies_not_supported&code=ce5aacf9-751f-4ab6-9ae4-e24f618a8581 Research programme: cell therapy - PanCELLa - AdisInsight PanCELLa is developing genetically modified cell lines using CRISPR genome-editing technology to treat difficult-to-treat diseases. PanCELLa will use CRISPR research programme cell therapy pancella adisinsight https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRMSCGSATS1F&year=2026 Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://cordis.europa.eu/programme/id/H2020_SC1-HCO-05-2016 Coordinating personalised medicine research | Programme | H2020 | CORDIS | European Commission personalised medicine research programme coordinating cordis european https://adisinsight.springer.com/drugs/800054135?error=cookies_not_supported&code=7d86858a-38af-4ffc-8bcc-ae13e70c086f Research programme: small molecule therapeutics - Gotham Therapeutics - AdisInsight Small molecules candidates against epitranscriptomics targets are being developed by Gotham Therapeutics (a subsidiary of 858 Therapeutics), for the treatment research programme small molecule therapeutics gotham adisinsight https://adisinsight.springer.com/drugs/800034662?error=cookies_not_supported&code=1141114f-4baa-4447-98e2-f795fc2a1320 Research programme: Helicobacter pylori vaccine - MIVAC Development - AdisInsight MIVAC Development is developing a vaccine against Helicobacter pylori (HP) infections for the prevention of gastric ulcer and gastric cancer. The vaccine research programme helicobacter pylori vaccine development adisinsight https://adisinsight.springer.com/drugs/800050882?error=cookies_not_supported&code=b60be828-f434-4244-b2df-4791a679e82c Research programme: Prader-Willi syndrome therapeutics - Levo Therapeutics - AdisInsight Levo therapeutics (a subsidiary of ACADIA Pharmaceuticals) is developing therapeutics for the treatment of Prader-Willi syndrome (PWS). The candidates will be prader willi syndrome research programme therapeutics levo adisinsight https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRPHDNATLP2P&year=2026 Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRMSCGENGE1F&year=2026 Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://adisinsight.springer.com/drugs/800034708?error=cookies_not_supported&code=73fef458-8dbe-4022-bc0b-092704e83a40 Research programme: intracellular biologic compounds - Permeon Biologics - AdisInsight Permeon Biologics is developing intraphilin compounds, a novel class of intracellular protein biologics, for the treatment of various diseases; the initial research programme intracellular biologic compounds adisinsight https://adisinsight.springer.com/drugs/800046251?error=cookies_not_supported&code=f8a517d3-0b19-46c6-bf4e-e31cbfe91a41 Research programme: mitochondrial angiotensin receptor antagonists - Gemstone Biotherapeutics -... Gemstone Biotherapeutics LLC was developing mitochondrial angiotensin receptor antagonists, utilising discoveries and technologies pioneered by researchers at research programme angiotensin receptor mitochondrial antagonists gemstone https://adisinsight.springer.com/drugs/800023125?error=cookies_not_supported&code=e0a5cfa8-efd4-4a54-9f5a-59b4133a266f Research programme: respiratory therapeutics - Galleon Pharmaceuticals - AdisInsight Galleon Pharmaceuticals of Philadelphia (Pennsylvania, USA) is developing oral and intravenous therapeutics for the treatment of breathing-control conditions; research programme respiratory therapeutics galleon pharmaceuticals https://adisinsight.springer.com/drugs/800050920?error=cookies_not_supported&code=6fd82ba4-edb3-4066-bd30-a498ee848026 Research programme: musculoskeletal disorder therapeutics - Boehringer Ingelheim - AdisInsight Boehringer Ingelheim is developing small molecule therapeutics for chronic musculoskeletal disorders, using proprietary paraxial mesoderm multipotent cells research programme boehringer ingelheim musculoskeletal disorder therapeutics https://adisinsight.springer.com/drugs/800087456?error=cookies_not_supported&code=d268ebf1-9b71-4124-8285-be18107ef14c Research programme: multiple sclerosis therapeutics - Dr. Noah Biotech - AdisInsight Combination drugs are being developed by Dr. Noah Biotech utilising ARK platform for the treatment of multiple sclerosis. Preclinical development is underway in research programme multiple sclerosis therapeutics dr noah https://www.xero.com/nz/legal/terms/ai-research-programme-survey-giveaway-terms/ AI Research Programme Survey Giveaway | Xero NZ ai research programme survey giveaway xero https://cordis.europa.eu/programme/id/FP7_IMI-Call-2009-Efficacy-06 Inflammation - Translational Research | Programme | FP7 | CORDIS | European Commission translational research inflammation programme cordis european https://datascience.hku.hk/study/summer-research-programme-2025/ Summer Research Programme 2025 - HKU Musketeers Foundation Institute of Data Science Jan 8, 2026 - A Huge Welcome to the HKU Summer Research Programme 2025, with HKU IDS! https://youtu.be/7ZSfq-AYG9s Join HKU IDS via the Summer Research Programme 2025! HKU... summer research programme institute of data hku https://adisinsight.springer.com/drugs/800028095?error=cookies_not_supported&code=fb811831-d205-4a8d-94ed-eccaf56f79e2 Research programme: VEGF gene therapy - Trizell - AdisInsight Trizell (formerly Ark Therapeutics) is developing a series of vascular endothelial growth factor (VEGF) gene variants as gene therapy for the treatment of research programme gene therapy vegf adisinsight https://adisinsight.springer.com/drugs/800026048?error=cookies_not_supported&code=c79eafce-d73d-485f-9b8e-ef996e7b1e5f Research programme: RNA targeting therapeutics - Syntara Limited/Santen - AdisInsight Ocular and intranasal formulations of RNA-targeting products for the treatment of allergic ocular diseases and allergic rhinitis were being developed by research programme rna targeting therapeutics limited https://adisinsight.springer.com/drugs/800031172?error=cookies_not_supported&code=96f7d1a1-072a-48a5-949a-2cc03cab454d Research programme: antibacterials - Calmune Corporation - AdisInsight Calmune Corporation (USA) is developing domain exchanged monoclonal antibodies for the treatment of bacterial infections. Domain exchanged antibodies (DXab) research programme antibacterials corporation adisinsight https://www.ar.admin.ch/en/research-programme-communications Research Programme 2 - Communications The areas of information and communications technologies are developing rapidly. The development cycles are correspondingly short and the risk thus high that... research programme communications https://adisinsight.springer.com/drugs/800033522?error=cookies_not_supported&code=73a186df-defc-4b59-9ce1-536842a0b861 Research programme: G protein-coupled receptor modulators - Evotec SE/Takeda Cambridge - AdisInsight Evotec SE (formerly Evotec AG) and Takeda Cambridge are collaborating to discover small molecule modulators against G protein-coupled receptor (GPCR) and research programme https://cordis.europa.eu/article/id/777-jrc-supplementary-research-programme-euratom-amended-proposal JRC supplementary research programme (Euratom): Amended proposal | News | CORDIS | European... An amendment to the proposal for a Council Decision adopting a supplementary research programme to be implemented by the Joint Research... research programme jrc supplementary euratom amended https://adisinsight.springer.com/drugs/800055343?error=cookies_not_supported&code=80599728-c3d7-4906-a387-301a00fbe0d2 Research programme: immune check point phosphatase modulators - Silicon therapeutics - AdisInsight Small molecule-based therapeutics targeting immune check point phosphatase (also known as phosphoric-monoester-hydrolase) are being developed by Silicon research programme check point immune phosphatase modulators https://adisinsight.springer.com/drugs/800030325?error=cookies_not_supported&code=43b2dc9f-3e86-48dc-9983-4051b7d9da6b Research programme: therapeutic agents - HUYA Biosciences International - AdisInsight HUYA Bioscience International is developing therapeutic compounds that cover a wide range of undisclosed therapeutic areas. The company has entered into a research programme therapeutic agents huya biosciences https://study.ed.ac.uk/programmes/postgraduate-research-fees?programme_code=PRMSCCARSC1P&year=2026 Research programme fees | Degree finder | The University of Edinburgh View annual tuition fees for this programme. research programme degree finder the university fees edinburgh https://adisinsight.springer.com/drugs/800042326?error=cookies_not_supported&code=81b50991-0e2c-4b51-9f93-49820decf8c4 Research programme: AAV-based gene therapies - Bristol-Myers Squibb/uniQure - AdisInsight uniQure and Bristol-Myers Squibb (BMS) are collaborating to develop a gene therapy, based on adeno-associated virus (AAV) vector discovery and optimisation bristol myers squibb research programme gene therapies aav based https://www.xero.com/id/legal/terms/ai-research-programme-survey-giveaway-terms/ AI Research Programme Survey Giveaway | Xero ID ai research programme survey giveaway xero https://adisinsight.springer.com/drugs/800039839?error=cookies_not_supported&code=3fe04e0c-8315-4839-b973-de0943f5ef88 Research programme: arthritis therapeutic - Eyegene - AdisInsight Eyegene in South Korea is developing a therapeutic for arthritic diseases, primarily osteoarthritis, but also potentially for rheumatoid arthritis. The company research programme arthritis therapeutic adisinsight https://cordis.europa.eu/article/id/158596-transnational-research-programme-advances-nanomedicine-research Transnational research programme advances nanomedicine research | EURONANOMED II Project | Results... Nanomedicine is the application of nanotechnology to health. An EU initiative added to the research being conducted in this important... research programme transnational advances nanomedicine ii https://adisinsight.springer.com/drugs/800040857?error=cookies_not_supported&code=781ac5e6-4937-43ca-a947-5b80e1d491ac Research programme: metabolic disorder therapeutics - Energesis Pharmaceuticals - AdisInsight research programme metabolic disorder therapeutics pharmaceuticals adisinsight https://adisinsight.springer.com/drugs/800087010?error=cookies_not_supported&code=5a773609-e2b5-4339-b68a-85630c57a7c2 Research programme: ROR1 targeting radiopharmaceutical cancer therapies - SK biopharmaceuticals -... Receptor tyrosine kinase like orphan receptor (ROR1) targeting radiopharmaceutical cancer therapies being developed by SK biopharmaceuticals for the treatment research programme cancer therapies targeting radiopharmaceutical sk https://www.timeshighereducation.com/news/supplementary-research-programme-item-approved-without-debate-extract-from-provisional-version-jha-council-19-feb/186944.article Supplementary research programme (Item Approved Without Debate - Extract from: Provisional Version,... research programme supplementary item approved https://adisinsight.springer.com/drugs/800087524?error=cookies_not_supported&code=91a91a9e-90b0-458c-a72f-bd658362512c Research programme: diabetic retinopathy therapeutics - Pikralida - AdisInsight First-in-class novel small molecule therapeutics are being developed by Pikralida, for the treatment of diabetic retinopathy. Preclinical development is research programme diabetic retinopathy therapeutics adisinsight